Pyridinium-based cationic lipids as gene-transfer agents

European Journal of Organic Chemistry

Volumn , Issue 14, 2003, Pages 2645-2655

  Ilies, Marc Antoniu ^a,d   Seitz, William A ^a   Caproiu, Miron T ^b   Wentz, Melissa ^c   Garfield, Robert E ^c   Balaban, Alexandru T ^a  

^a TEXAS A AND M UNIVERSITY AT GALVESTON   (United States)

^b INSTITUTE OF ORGANIC CHEMISTRY   (Romania)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d UNIVERSITY OF AGRONOMIC SCIENCES AND VETERINARY MEDICINE OF BUCHAREST   (Romania)

Author keywords

Cationic lipids; Gene transfer agents; Liposomes; Nitrogen heterocycles; NMR spectroscopy; Transfection

Indexed keywords

1 (1,3 DIOLEOYLOXYPROPAN 2 YL) 2,4,6 TRIMETHYLPYRIDINIUM PERCHLORATE; 1 (1,3 DIOLEOYLOXYPROPAN 2 YL) 2,4,6 TRIMETHYLPYRIDINIUM TETRAFLUOROBORATE; 1 (1,3 DIPALMITOYLOXYPROPAN 2 YL) 2,4,6 TRIMETHYLPYRIDINIUM TETRAFLUOROBORATE; 1 (1,3 DIPALMITOYLOXYPROPAN 2 YL) 2,4,6 TRIPHENYLPYRIDINIUM PERCHLORATE; 1 (1,3 DIPAMITOYLOXYPROPAN 2 YL) 2,4,6 TRIMETHYLPYRIDINIUM; 1 (1,3 DISTEAROYLOXYPROPAN 2 YL) 2,4,6 TRIMETHYLPYRIDINIUM; 1 (1,3 DISTEAROYLOXYPROPAN 2 YL) 2,4,6 TRIMETHYLPYRIDINIUM TETRAFLUOROBORATE; 1 (2,3 DIOLEOYLOXYPROPYL) 2,4,6 TRIMETHYLPYRIDINIUM TETRAFLUOROBORATE; 1 (2,3 DIPALMITOYLOXYPROPYL) 2,4,6 TRIMETHYLPYRIDINIUM; 1 (2,3 DIPALMITOYLOXYPROPYL) 2,4,6 TRIPHENYLPYRIDIUNIUM PERCHLORATE; 1 (2,3 DISTEAROYLOXYPROPYL) 2,4,6 TRIMETHYLPYRIDINIUM; 1 (2,3 DISTEAROYLOXYPROPYL) 2,4,6 TRIMETHYLPYRIDINIUM TETRAFLUOROBORATE; ALKENE; CATIONIC LIPID; HETEROCYCLIC AMINE; IMIDAZOLE DERIVATIVE; LIPID; PYRIDINIUM DERIVATIVE; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; CELL LINE; CYTOTOXICITY; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HYDROPHOBICITY; IMMUNOGENICITY; LIPOPHILICITY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLASMID VECTOR; PROTON NUCLEAR MAGNETIC RESONANCE; VIRUS VECTOR;

EID: 0042346425     PISSN: 1434193X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ejoc.200300106     Document Type: Article

References (32)

1. N. S. Templeton, D. D. Lasic, in Gene Therapy. Therapeutical Mechanisms and Strategies, Marcel Dekker, New York, Basel, 2000.
2. A. Mountain, Trends Biotechnol. 2000, 18, 119-128.
3. N. R. Lemoine, D. N. Cooper, in Human Molecular Genetics (Eds.: D. N. Cooper, S. E. Humphries, T. Strachan), BIOS Scientific Publishers, Oxford, 1996.
4. O. Greco, S. D. Scott, B. Marples, G. U. Dachs, Front. Biosci. 2002, 7, 1516-1524.
5. M. A. Kay, J. C. Glorioso, L. Naldini, Nat. Med. 2001, 7, 33-40.
6. W. Walther, U. Stein, Drugs 2000, 60, 249-271.
7. M. A. Ilies, W. A. Seitz, A. T. Balaban, Curr. Pharm. Des. 2002, 8, 2441-2473.
8. M. A. Ilies, A. T. Balaban, Expert Opin. Ther. Patents 2001, 11, 1729-1752.
9. S. Li, L. Huang, Gene Ther. 2000, 7, 31-34.
10. A. D. Miller, Angew. Chem. Int. Ed. 1998, 37, 1768-1785.
11. P. L. Felgner, J. Gene Med. 1999, 1, 290-292.
12. P. L. Felgner, Y. Barenholz, J.-P. Behr, S. H. Cheng, P. Cullis, L. Huang, J. A. Jessee, L. Seymour, F. C. Szoka, Jr., A. R. Thierry, Hum. Gene Ther. 1997, 8, 511-512.
13. C. R. Safinya, Curr. Opin. Struct. Biol. 2001, 11, 440-448.
14. S. Chesnoy, L. Huang, Annu. Rev. Biophys. Biomol. Struct. 2000, 29, 27-47.
15. N. J. Zuidam, Y. Barenholz, Biochim. Biophys. Acta 1998, 1368, 115-128.
16. S. J. Hwang, M. E. Davis, Curr. Opin. Mol. Ther. 2001, 3, 183-191.
17. I. Solodin, C. S. Brown, M. S. Bruno, C. Y. Chow, E. H. Jang, R. J. Debs, T. D. Heath, Biochemistry 1995, 34, 13537-13544.
18. I. van der Woude, A. Wagenaar, A. A. Meekel, M. B. ter Beest, M. H. Ruiters, J. B. Engberts, D. Hoekstra, Proc. Natl. Acad. Sci. U S A 1997, 94, 1160-1165.
19. A. A. P. Meekel, A. Wagenaar, J. Smisterova, J. E. Kroeze, P. Haadsma, B. Bosgraaf, M. C. A. Stuart, A. Brisson, M. H. J. Ruiters, D. Hoekstra, J. B. F. N. Engberts, Eur. J. Org. Chem. 2000, 665-673.
20. I. van der Woude, H. W. Visser, M. B. ter Beest, A. Wagenaar, M. H. Ruiters, J. B. Engberts, D. Hoekstra, Biochim. Biophys. Acta 1995, 1240, 34-40.
21. J. Smisterova, A. Wagenaar, M. C. Stuart, E. Polushkin, G. ten Brinke, R. Hulst, J. B. Engberts, D. Hoekstra, J. Biol. Chem. 2001, 276, 47615-47622.
22. A. Hassner, C. Stumer, in Organic Syntheses Based on Named Reactions, 2nd Ed., Pergamon Press, Amsterdam, 2002, p. 4.
23. A. T. Balaban, A. Dinculescu, G. N. Dorofeenko, G. W. Fischer, A. V. Koblik, V. V. Mezheritskii, W. Schroth, in Advances in Heterocyclic Chemistry (Ed.: A. R. Katritzky), Academic Press, New York, 1982.
24. W. Schroth, A. T. Balaban, in Methoden der Organischen Chemie (Houben-Weyl), Vol. E7b (Ed.: R. P. Kreher), G. Thieme Verlag, Stuttgart, 1992, p. 755-963.
25. A. T. Balaban, W. A. Seitz, M. A. Ilies, M. Wentz, R. E. Garfield, US Provisional Patent Application 2002, 60/391961.
26. T. S. Balaban, A. T. Balaban, in Science of Synthesis. Houben-Weyl Methods of Molecular Transformations, Vol. 14 (Ed.: E. J. Thomas), G. Thieme Verlag, Stuttgart, 2003.
27. A. T. Balaban, in Encyclopedia of Reagents for Organic Synthesis, Vol. 7 (Ed.: L. A. Paquette), Wiley, New York, 1996, pp. 5224-5227.
28. A. T. Balaban, in Encyclopedia of Reagents for Organic Synthesis, Vol. 8 (Ed.: L. A. Paquette), Wiley, New York, 1996, pp. 5407-5411.
29. A. T. Balaban, C. Uncuta, M. Elian, F. Chiraleu, A. Dinculescu, Tetrahedron 1984, 40, 2547-2553.
30. C. Uncuta, I. Paun, A. Ghitescu, C. Deleanu, T. S. Balaban, F. Chiraleu, M. D. Gheorghiu, A. T. Balaban, Tetrahedron Lett. 1990, 31, 5645-5648.
31. R. Leventis, J. R. Silvius, Biochim. Biophys. Acta 1990, 1023, 124-132.
32. K. A. Mislick, J. D. Baldeschwieler, Proc. Natl. Acad. Sci. USA 1996, 93, 12349-12354.